http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-464648-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1998-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cfa038b004f9413784405815b285c71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01d467c8ab43b6003a42cf8de7b47771 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f02eadb7dd685b522cf7ff0db7298fa9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a695e8b63598835fafabe2a40221633 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_033f175937882d6b6bacfb34695a95bb |
| publicationDate | 2001-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-464648-B |
| titleOfInvention | Substituted 2, 4-diaminopyrimidines having antibacterial activity, preparation thereof and pharmaceutical composition comprising the same |
| abstract | The invention is concerned with compounds of the general formula wherein R1 signifies unsubstituted and substituted C1-6-alkoxy; R2 signifies hydroxy or unsubstituted nd substituted or C1-6-alkoxy; R3 signifies hydrogen, cyano, unsubstituted and substituted C1-6-alkyl, unsubstituted and substituted C2-6-alkenyl, unsubstituted and substituted C3-6-cycloalkyl, unsubstituted and substituted bicyclyl, unsubstituted and substituted C6-14-aryl, unsubstituted and substituted heterocyclyl characterized as 4 to 6 membered rings with 1 to 3 N, O and/or S atoms, unsubstituted and substituted heteroaryl characterized as 5- or 6- membered, mono- or poly-nuclear heteroaromatic groups with 5-13 carbon atoms and 1-4 hetero atoms selected from nitrogen, oxygen and/or sulphur atoms, unsubstituted and substituted C7-20-aralkyl, unsubstituted and substituted C6-14-aryl-Q-C1-6-alkyl, unsubstituted and substituted heterocyclyl-C1-6-alkyl (in which ""heterocyclyl"" is as above) or a group of the formula -CR4R4'COR5; signifies -SO- or SO2; R4, R4' each independently signify hydrogen, unsubstituted and substituted C1-6-alkyl, unsubstituted and substituted C6-14-aryl or unsubstituted and substituted heterocyclyl characterized as 4 to 6 membered rings with 1 to 3 N, O and/or S atoms; R5 signifies hydrogen, unsubstituted and substituted C1-6-alkyl, unsubstituted and substituted C1-6-alkoxy, unsubstituted and substituted C6-14-aryl or unsubstituted and substituted heterocyclyl characterized as 4 to 6 membered rings with 1 to 3 N, O and/or S atoms; as well as pharmaceutically usable salts thereof. The use of these compounds and their salts as therapeutically active substances; medicaments based on these substances and their production; the use of these substances as medicaments and for the production of antibacterially-active medicaments; as well as the manufacture of the compounds of formula I and their pharmaceutically acceptable salts and intermediates for their manufacture. |
| priorityDate | 1997-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 378.